INT58439

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.42
First Reported 1993
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 5
Disease Relevance 0.88
Pain Relevance 0.39

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (Gnat3) GTPase activity (Gnat3) cytoplasm (Gnat3)
signal transducer activity (Gnat3)
Anatomy Link Frequency
coronary artery 2
Gnat3 (Mus musculus)
Pain Link Frequency Relevance Heat
Angina 7 100.00 Very High Very High Very High
Bioavailability 8 92.96 High High
tolerance 34 44.20 Quite Low
Glutamate 4 31.56 Quite Low
addiction 10 5.00 Very Low Very Low Very Low
Potency 4 5.00 Very Low Very Low Very Low
ischemia 2 5.00 Very Low Very Low Very Low
alcohol 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Coronary Artery Disease 4 100.00 Very High Very High Very High
Angina 3 100.00 Very High Very High Very High
Increased Venous Pressure Under Development 8 94.72 High High
Hypertension 5 86.80 High High
Complex Regional Pain Syndromes 1 72.56 Quite High
Cv General 3 Under Development 3 71.56 Quite High
Myocardial Infarction 1 70.72 Quite High
Targeted Disruption 2 5.00 Very Low Very Low Very Low
Stress 2 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
After administration of GTN, SBP was decreased significantly from 157 +/- 25 to 142 +/- 23 mmHg (P < 0.01), while DBP did not change (83 +/- 13 vs 84 +/- 15 mmHg).
Negative_regulation (decreased) of Gene_expression (administration) of GTN
1) Confidence 0.42 Published 1993 Journal Angiology Section Abstract Doc Link 8285372 Disease Relevance 0.59 Pain Relevance 0.22
Importantly, ALDH2-catalyzed GTN
reduction was partly inactivated by preincubation with GTN, suggesting that
the inactivation of GTN reduction is also partly irreversible. 
Negative_regulation (inactivation) of Gene_expression (reduction) of GTN
2) Confidence 0.21 Published 2008 Journal The Journal of Biological Chemistry Section Abstract Doc Link PMC2576553 Disease Relevance 0 Pain Relevance 0
SCHEME 1.Irreversible inactivation of ALDH-catalyzed GTN reduction.
Negative_regulation (inactivation) of Gene_expression (reduction) of GTN
3) Confidence 0.18 Published 2008 Journal The Journal of Biological Chemistry Section Body Doc Link PMC2576553 Disease Relevance 0 Pain Relevance 0
Under these conditions, the effect of ALDH2/GTN even exceeded that of 10 ?
Negative_regulation (exceeded) of Gene_expression (effect) of GTN
4) Confidence 0.11 Published 2010 Journal The Journal of Biological Chemistry Section Body Doc Link PMC2801295 Disease Relevance 0 Pain Relevance 0.05
Another study reported that the efficacious rate of sublingual GTN, measured as reduction of ischemic chest pain of patients having documented coronary artery disease, was reduced from 85.1% in controls to 57.6% in subjects carrying at least one ALDH2*2 allele (24).
Negative_regulation (reduced) of Gene_expression (rate) of GTN in coronary artery associated with angina and coronary artery disease
5) Confidence 0.10 Published 2010 Journal The Journal of Biological Chemistry Section Body Doc Link PMC2801295 Disease Relevance 0.29 Pain Relevance 0.13

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox